Molecular Therapy — Oncolytics

771 papers and 16.6k indexed citations i.

About

The 771 papers published in Molecular Therapy — Oncolytics in the last decades have received a total of 16.6k indexed citations. Papers published in Molecular Therapy — Oncolytics usually cover Molecular Biology (389 papers), Oncology (355 papers) and Genetics (322 papers) specifically the topics of Virus-based gene therapy research (312 papers), CAR-T cell therapy research (249 papers) and Immunotherapy and Immune Responses (100 papers). The most active scholars publishing in Molecular Therapy — Oncolytics are Isabelle Rivière, Xiuyan Wang, Challice L. Bonifant, Renier J. Brentjens, Kevin J. Curran, Aiping Tong, Steven Μ. Albelda, Marco L. Davila, Yuman Fong and Daniel Abate‐Daga.

In The Last Decade

Fields of papers published in Molecular Therapy — Oncolytics

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Molecular Therapy — Oncolytics. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Molecular Therapy — Oncolytics

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Molecular Therapy — Oncolytics. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Molecular Therapy — Oncolytics with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025